Staidson (300204.SZ): STSP-0902 Injection (for the treatment of oligoasthenospermia) obtained the Phase Ib clinical study summary report.
Staidson (300204.SZ) announced that the company recently obtained the Phase Ib clinical study summary report for STSP-0902 Injection for the treatment of oligoasthenospermia. In healthy trial participants, within the dose range designed in the protocol, multiple subcutaneous injections and single subcutaneous injections of STSP-0902 Injection demonstrated good safety and tolerability, and an upward trend from baseline in semen parameters was observed after multiple administrations. In healthy trial participants, within the dose range designed in the protocol, no ADA positivity was observed for either multiple subcutaneous injections or single subcutaneous injections of STSP-0902 Injection, indicating low immunogenicity. The trial results support further clinical research on STSP-0902 Injection.
Staidson (300204.SZ) announced that the company recently obtained the Phase Ib clinical study summary report for STSP-0902 Injection for the treatment of oligoasthenospermia. In healthy trial participants, within the dose range designed in the protocol, multiple subcutaneous injections and single subcutaneous injections of STSP-0902 Injection demonstrated good safety and tolerability, and an upward trend in semen parameters compared with baseline was observed after multiple dosing. In healthy trial participants, within the dose range designed in the protocol, no ADA positivity was observed for either multiple subcutaneous injections or single subcutaneous injections of STSP-0902 Injection, indicating low immunogenicity. The trial results support further clinical research on STSP-0902 Injection.
Related Articles
MOBVISTA (01860) repurchased 150,000 shares on September 25 for HK$1.8427 million.
SCHOLAR EDU (01769): Trustee purchases 200,000 shares under the share award scheme
BAIRONG AI-W (06608) repurchased 8,000 shares for HK$36,500 on September 25.
MOBVISTA (01860) repurchased 150,000 shares on September 25 for HK$1.8427 million.
SCHOLAR EDU (01769): Trustee purchases 200,000 shares under the share award scheme
BAIRONG AI-W (06608) repurchased 8,000 shares for HK$36,500 on September 25.
